Deepak Nitrite Limited CC-Mar24.pdf · 2024-05-22
Just a couple. So, one is on the Phenolics segment. This quarter we have seen about a 9% quarter- on-quarter increase in revenues. Is that entirely volume driven? And if so, can we expect this same level of capacity utilization to sustain through fiscal year 2025 going forward?
That’s helpful. And the other one was on the Advanced Intermediates segment. If I adjust for this insurance benefit of about Rs. 80 crore, the margins seem to have compressed quite significantly somewhere to about 9% or so, 8 -9%. So, from the first half perspective for next year, should we expect similar margins before they sort of start to come back towards mid-teens in the second half of the year? Is that how we should think about it?